Matthew D’Ambrosio
Directeur/Membre du Conseil chez BRIGHTSPRING HEALTH SERVICES, INC.
Fortune : 11 250 $ au 31/05/2024
Profil
Matthew D’Ambrosio currently works at BrightSpring Health Services, Inc., as Independent Director from 2022.
Mr. D’Ambrosio also formerly worked at Sumitomo Pharma America, Inc., as Chief Compliance & Ethics Office from 2010 to 2017 and Reliant Pharmaceuticals LLC, as Chief Compliance Office.
Mr. D’Ambrosio received his Masters Business Admin degree from Rutgers State University of New Jersey, undergraduate degree from Rider University, and graduate degree from Seton Hall University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2024 | 1 000 ( 0,00% ) | 11 250 $ | 31/05/2024 |
Postes actifs de Matthew D’Ambrosio
| Sociétés | Poste | Début |
|---|---|---|
| BRIGHTSPRING HEALTH SERVICES, INC. | Directeur/Membre du Conseil | 01/10/2022 |
Anciens postes connus de Matthew D’Ambrosio
| Sociétés | Poste | Fin |
|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Compliance Officer | 01/11/2017 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Compliance Officer | - |
Formation de Matthew D’Ambrosio
| Rutgers State University of New Jersey | Masters Business Admin |
| Rider University | Undergraduate Degree |
| Seton Hall University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRIGHTSPRING HEALTH SERVICES, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
